Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Journal of Photochemistry and Photobiology. B, Biology|September 28, 2011
De novo design of chiral organotin cancer drug candidates: validation of enantiopreferential binding to molecular target DNA and 5'-GMP by UV-visible, fluorescence, (1)H and (31)P NMRFarukh Arjmand, Girish Chandra Sharma, Fatima Sayeed, et al.
Dalton Transactions (Cambridge, England : 2003)|December 7, 2013
Carbohydrate linked organotin(IV) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell lineRais Ahmad Khan, Shipra Yadav, Zahid Hussain, et al.
European Journal of Medicinal Chemistry|February 7, 2012
Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studiesFarukh Arjmand, Shazia Parveen, Mohd Afzal, et al.
International Journal of Biological Macromolecules|May 20, 2018
Exploring the intermolecular interactions and contrasting binding of flufenamic acid with hemoglobin and lysozyme: A biophysical and docking insightSameer Shakeel Ansari, Imtiyaz Yousuf, Farukh Arjmand, et al.
Toxicology and Applied Pharmacology|May 25, 2022
Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stressDeepti Singh, Mohammad Afsar Khan, Kafil Akhtar, et al.
Journal of Biomolecular Structure & Dynamics|March 17, 2020
Molecular docking, DFT and antimicrobial studies of Cu(II) complex as topoisomerase I inhibitorShazia Parveen, Farukh Arjmand, Qianfan Zhang, et al.
Pageof 10